These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effect of Different Ablation Settings on Acute Complications Using the Novel Irrigated Multipolar Radiofrequency Ablation Catheter (nMARQ). Deneke T; Müller P; Halbfaß P; Szöllösi A; Roos M; Krug J; Fochler F; Schade A; Schmitt R; Christopoulos G; Mügge A; Nentwich K J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1063-8. PubMed ID: 26076115 [TBL] [Abstract][Full Text] [Related]
27. Laser lead extraction to facilitate cardiac implantable electronic device upgrade and revision in the presence of central venous obstruction. Sohal M; Williams S; Akhtar M; Shah A; Chen Z; Wright M; O'Neill M; Patel N; Hamid S; Cooklin M; Bucknall C; Bostock J; Gill J; Rinaldi CA Europace; 2014 Jan; 16(1):81-7. PubMed ID: 23794614 [TBL] [Abstract][Full Text] [Related]
28. Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory? McCready JW; Nunn L; Lambiase PD; Ahsan SY; Segal OR; Rowland E; Lowe MD; Chow AW Europace; 2010 Jul; 12(7):927-32. PubMed ID: 20304842 [TBL] [Abstract][Full Text] [Related]
29. The long term risk of lead failure in patients with cardiovascular implantable electronic devices undergoing catheter ablation. Farkowski MM; Maciag A; Ciszewski J; Kowalik I; Syska P; Sterlinski M; Szwed H; Pytkowski M Scand Cardiovasc J; 2019 Dec; 53(6):323-328. PubMed ID: 31407601 [No Abstract] [Full Text] [Related]
30. Catheter ablation of atrial fibrillation in patients at low thrombo-embolic risk: efficacy and safety of a simplified periprocedural anticoagulation strategy. Duytschaever M; Berte B; Acena M; De Meyer G; Bun SS; Van Heuverswyn F; Vandekerckhove Y; Tavernier R J Cardiovasc Electrophysiol; 2013 Aug; 24(8):855-60. PubMed ID: 23600918 [TBL] [Abstract][Full Text] [Related]
31. Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections. Krishnamoorthy A; Pokorney SD; Lewis RK; Daubert JP; Greenfield RA; Hegland DD; Milano CA; Rogers JG; Schroder JN; Patel CB; Piccini JP J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1199-205. PubMed ID: 24890850 [TBL] [Abstract][Full Text] [Related]
32. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin. Kim JS; Jongnarangsin K; Latchamsetty R; Chugh A; Ghanbari H; Crawford T; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):302-9. PubMed ID: 23443620 [TBL] [Abstract][Full Text] [Related]
33. Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures. Bunch TJ; Crandall BG; Weiss JP; May HT; Bair TL; Osborn JS; Anderson JL; Lappe DL; Muhlestein JB; Nelson J; Allison S; Foley T; Anderson L; Day JD J Cardiovasc Electrophysiol; 2009 Sep; 20(9):988-93. PubMed ID: 19473299 [TBL] [Abstract][Full Text] [Related]
34. An 8-year single-centre experience of cardiac resynchronisation therapy: procedural success, early and late complications, and left ventricular lead performance. Ahsan SY; Saberwal B; Lambiase PD; Chaubey S; Segal OR; Gopalamurugan AB; McCready J; Rogers DP; Lowe MD; Chow AW Europace; 2013 May; 15(5):711-7. PubMed ID: 23315159 [TBL] [Abstract][Full Text] [Related]
35. Comparison of standard and modified transvenous techniques for complex pacemaker lead extractions in the context of cardiac implantable electronic device-related infections: a 10-year experience. Zhou X; Jiang H; Ma J; Bakhai A; Li J; Zhang Y; Li Y; Wang D; Zhang Y; Xu G; Zhang J; Tang B Europace; 2013 Nov; 15(11):1629-35. PubMed ID: 23887094 [TBL] [Abstract][Full Text] [Related]